Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
02/1999
02/18/1999WO1999007882A1 Fluorescent polymeric sensor for the detection of urea
02/18/1999WO1999007881A1 Fluorescent polymeric sensor for the detection of creatinine
02/18/1999WO1999007879A1 Electrochemical reporter system for detecting analytical immunoassay and molecular biology procedures
02/18/1999WO1999007878A1 Ion-sensitive sensor devices and analytical methods using them
02/18/1999WO1999007877A1 Biosensor for detecting adenosine
02/18/1999WO1999007866A1 Matrix attachment regions
02/18/1999WO1999007856A1 Novel metalloprotease
02/18/1999WO1999007850A1 Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides
02/18/1999WO1999007843A1 Human glial cell line-derived neurotrophic factor promoters, vectors containing same, and methods of screening compounds therewith
02/18/1999WO1999007842A1 Materials and methods for selecting phage displaying ligand binders
02/18/1999WO1999007836A1 Kinase activating dependent cyclin protein kinases, and their uses
02/18/1999WO1999007832A1 Kcnq potassium channels and methods of modulating same
02/18/1999WO1999007828A1 Dna molecules encoding ctenocephalides felis glutamate gated chloride channels
02/18/1999WO1999007824A1 Cuvette for performing a diagnostic test on a specimen
02/18/1999WO1999007741A1 Meningococcus vaccine comprising the valence of bz83 strain
02/18/1999WO1999007740A2 Lipocalin homologs
02/18/1999WO1999007737A2 Lsr receptor, cloning and uses
02/18/1999WO1999007736A2 Lipoprotein-regulating medicaments
02/18/1999WO1999007726A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same
02/18/1999WO1999007725A1 EXPRESSION OF NEUROGENIC bHLH GENES IN PRIMITIVE NEUROECTODERMAL TUMORS
02/18/1999WO1999007724A1 Systematic evolution of ligands by exponential enrichment: tissue selex
02/18/1999WO1999007722A1 Oligonucleotide specific of the escherichia coli species and method for detecting and displaying bacteria of this species
02/18/1999WO1999007207A1 Hypersensitive response elicitor from pseudomonas syringae and its use
02/18/1999WO1998051816A3 System for measuring the efficacy of a sterilization cycle
02/18/1999WO1998050584A3 Nucleic acids for detecting aspergillus species and other filamentous fungi
02/18/1999WO1998049290A3 Syndecan interacting proteins and the use thereof
02/18/1999WO1998045473A3 Dna probes for campylobacter, arcobacter and helicobacter
02/18/1999WO1998014593A3 Human telomerase catalytic subunit
02/18/1999DE19736156A1 Analysis of substance concentration in fluid sample
02/18/1999DE19735614A1 Detection of protease activity for insulin-like growth factor binding proteins
02/18/1999DE19734940A1 Nucleinsäuremolekül-Satz für Salmonella-Nachweis, Nucleinsäuren, Kit und Verwendung Nucleic acid kit for Salmonella detection, nucleic acids, Kit and use
02/18/1999DE19731684A1 Reagent for determining plasma sample by measuring clotting time
02/18/1999CA2300985A1 Kcnq potassium channels and methods of modulating same
02/18/1999CA2300439A1 Kinase activating dependent cyclin protein kinases, and their uses
02/18/1999CA2300369A1 Method and kit for hla class i typing dna
02/18/1999CA2300268A1 Electrochemical reporter system for detecting analytical immunoassay and molecular biology procedures
02/18/1999CA2300144A1 The use of primers for universal fingerprint analysis
02/18/1999CA2299630A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same
02/18/1999CA2299618A1 Dna molecules encoding ctenocephalides felis glutamate gated chloride channels
02/18/1999CA2299605A1 90 human secreted proteins
02/18/1999CA2299599A1 Oligonucleotide specific of the escherichia coli species and method for detecting and displaying bacteria of this species
02/18/1999CA2299563A1 Hypersensitive response elicitor from pseudomonas syringae and its use
02/18/1999CA2299299A1 Detection of wheat fungal pathogens using the polymerase chain reaction
02/18/1999CA2299226A1 Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides
02/18/1999CA2298849A1 Lipoprotein-regulating medicaments
02/18/1999CA2298439A1 Lipocalin homologs
02/18/1999CA2298140A1 Detection and confirmation of nucleic acid sequences by use of oligonucleotides comprising a subsequence hybridizing exactly to a known terminal sequence and a subsequence hybridizing to an unidentified sequence
02/18/1999CA2298052A1 Matrix attachment regions
02/18/1999CA2298019A1 Denaturing multi ion polynucleotide chromatography for detecting mutations
02/18/1999CA2296598A1 Isolation of a novel senescence-factor gene, p23
02/18/1999CA2274302A1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
02/18/1999CA2267066A1 Meningococcus vaccine comprising the valence of bz83 strain
02/17/1999EP0897114A2 A method of identifying agonist and antagonists for tumor necrosis related receptors TR1 and TR2
02/17/1999EP0897015A2 Method for evaluating drug metabolism and reagent compositions therefor
02/17/1999EP0897011A2 Novel arginine deiminase
02/17/1999EP0897007A2 MraY transferase
02/17/1999EP0897004A2 Histidyl tRNA synthetase from Streptococcus pneumoniae (hisS)
02/17/1999EP0897001A1 Polypeptide having a GTPase regulator activity, nucleic acids coding therefore and their use in diagnostics and therapy
02/17/1999EP0896634A1 Method for determining tandem repeat sequence length
02/17/1999EP0896633A2 5-lipoxygenase gene polymorphisms and their use in classifying patients
02/17/1999EP0896632A1 Method, compositions and kit for detection and identification of microorganisms
02/17/1999EP0896631A1 METHOD FOR SIMULTANEOUS DETECTION OF MULTIPLE FLUOROPHORES FOR $i(IN SITU) HYBRIDIZATION
02/17/1999EP0896630A1 Method for detecting a nucleic acid base sequence
02/17/1999EP0896629A1 Methods and compositions for detecting dihydropyrimidine dehydrogenase splicing mutations
02/17/1999EP0896623A1 Immunity to trypanosomatids species
02/17/1999EP0896622A1 Chemokine alpha 2
02/17/1999EP0896620A1 Modified nuclear glucocorticoid receptor, fusion protein, and dna fragments coding for said receptor and said fusion protein
02/17/1999EP0896615A1 Peptide from soluble form of acetylcholinesterase, active as a calcium channel modulator
02/17/1999CN1208441A A method for high-sensitive silver staining
02/17/1999CN1208420A Antisecretory factor peptides regulating pathological permeability changes
02/17/1999CN1208078A Genes encoding branched-chain alpha-ketoacid dehydrogense complex from streptomyces Avermitilis
02/16/1999US5873052 Alignment-based similarity scoring methods for quantifying the differences between related biopolymer sequences
02/16/1999US5872713 For detecting the presence of an analyte in a sample
02/16/1999US5872237 Isolated nucleic acid sequences of dna or cdna for gene expression and dna sequences
02/16/1999US5872235 Nucleic acids encoding tumor marker
02/16/1999US5872234 Antitumor
02/16/1999US5872232 2'-O-modified oligonucleotides
02/16/1999US5872231 Nucleic acids encoding merosin
02/16/1999US5872226 Fibroblast growth factor homologous factor-1 (FHF-1)
02/16/1999US5872219 Antibodies drawn to the eps15 substrate for epidermal growth factor receptor kinase
02/16/1999US5872212 Pesticidal proteins and strains
02/16/1999US5872209 Artificial recombinant substrate (rAGG 1) and native aggrecan to determine the proteolytic activity of `aggrecanase` in cell culture systems
02/16/1999US5872107 Anticarcinogenic agents capture therapy for tumors
02/16/1999US5872105 Antiparallel binding domain
02/16/1999US5872014 Assay for multi-drug resistance
02/16/1999US5872008 Methods for diagnosing pre-menstrual syndrome
02/16/1999US5872006 Family of MAP2 protein kinases
02/16/1999US5872003 DNA sequencing by mass spectrometry via exonuclease degradation
02/16/1999US5871998 Gene expression in transformed eukaryotic host cell; genetic engineering
02/16/1999US5871996 First agent comprising isolated virus having reverse transcriptase activity, second agent distinct from first, comprising nucleotides; both agents associated with multiple sclerosis and purifiable from viral isolate pol-2 and ms7pg
02/16/1999US5871976 Genetic engineering
02/16/1999US5871975 Method for suppressing inhibition of enzyme-mediated nucleic acid amplification reactions by ionic detergents
02/16/1999US5871973 Cell division regulators
02/16/1999US5871967 Cloning of a novel G-Protein coupled 7TM receptor
02/16/1999US5871962 Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods
02/16/1999US5871961 Nucleic acids encoding CR2 polypeptides, vector and transformed cell thereof, and expression thereof
02/16/1999US5871960 Nucleic acids encoding CR5 polypeptide, vector and transformed cell thereof, and expression thereof
02/16/1999US5871952 Process for selection of Oxygen-tolerant algal mutants that produce H2
02/16/1999US5871951 Bactericides by the disrupting the addition of choline
02/16/1999US5871950 Methods of treating autoimmune diseases and transplantation rejection